ARTICLE | Company News
AstraZeneca receives approval for Atacand HCT
September 5, 2000 7:00 AM UTC
The FDA approved AZN's Atacand HCT candesartan cilexetilhydrochlorothiazide combination product for second-line treatment of hypertension. AZN said the product, which combines an angiotensin II recept...